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Crystal structure of decameric 2-Cys peroxiredoxin from human
erythrocytes at 1.7 Å resolution
Ewald Schröder1*, Jennifer A Littlechild1*, Andrey A Lebedev1, Neil Errington2,
Alexei A Vagin3 and Michail N Isupov1
Background: The peroxiredoxins (Prxs) are an emerging family of
multifunctional enzymes that exhibit peroxidase activity in vitro, and in vivo
participate in a range of cellular processes known to be sensitive to reactive
oxygen species. Thioredoxin peroxidase B (TPx-B), a 2-Cys type II Prx from
erythrocytes, promotes potassium efflux and down-regulates apoptosis and the
recruitment of monocytes by endothelial tissue.
Results: The crystal structure of human decameric TPx-B purified from
erythrocytes has been determined to 1.7 Å resolution. The structure is a toroid
comprising five dimers linked end-on through predominantly hydrophobic
interactions, and is proposed to represent an intermediate in the in vivo reaction
cycle. In the crystal structure, Cys51, the site of peroxide reduction, is oxidised
to cysteine sulphinic acid. Cys172, the second catalytic cysteine residue, lies
~10 Å away from Cys51 and in this conformation of TPx-B is too distant to
recycle the activity of Cys51.
Conclusions: The oxidation of Cys51 appears to have trapped the structure
into a stable decamer, as confirmed by sedimentation analysis. A comparison
with two previously reported dimeric Prx structures reveals that the catalytic
cycle of 2-Cys Prx requires significant conformational changes that include the
unwinding of the active-site helix and the movement of four loops. It is proposed
that the stable decamer forms in vivo under conditions of oxidative stress.
Similar decameric structures of TPx-B have been observed by electron
microscopy, which show the protein associated with the erythrocyte membrane.
Introduction
Peroxiredoxin (Prx) enzymes [1,2] are preferentially
expressed under conditions of stress induced by elevated
levels of reactive oxygen species (ROS) and reactive nitro-
gen species [3]. Mammalian Prx enzymes down-regulate a
range of redox-sensitive processes including apoptosis,
mitochondrial permeability, tyrosine kinase activity and
the transcriptional activity of NF-κB and activator protein-
1 [1,2]. Mammalian Prx enzymes can be subdivided into at
least five subfamilies on the basis of protein sequence and
cellular localisation [1,2,4].
In common with the glutathione peroxidases (GPxs), Prx
enzymes are able to reduce hydrogen peroxide and alkyl
(lipid) hydroperoxides (ROOH) to water or the corre-
sponding alcohol (ROH), respectively. Prx activity is
dependent upon the presence of either a single (1-Cys
Prx) or a pair (2-Cys Prx) of highly conserved cysteine
residues that catalyse the peroxide reduction step within
the proposed mechanism [5–7]. Thioredoxin has been
shown to be the direct in vivo hydrogen donor for many
2-Cys Prx enzymes (the thioredoxin peroxidases) but
has no effect upon 1-Cys Prx activity, which is known
to be dependent upon small thiol reducing agents [2,7].
The direct reduction of sulphur-containing free radicals
cannot be excluded as an additional biochemical
activity [4,5]. 
Thioredoxin peroxidase B (TPx-B) is a 2-Cys type II Prx,
in accordance with the most recent nomenclature [1].
TPx-B was previously known as natural killer enhancing
factor-B (NKEF-B) [8] and as thioredoxin-linked peroxi-
dase [9], and is now known to be the same as calpromotin
[10–12], torin [13,14] (R Harris, personal communication)
and band 8 protein [15] (R Harris, personal communica-
tion). The TPx-B protein is 198 residues in length with a
molecular weight of ~22 kDa [8,11]. The cellular concen-
tration of TPx-B is 5.6 mg ml–1 (or 14 million copies per
cell), and is therefore the third most abundant protein
found in the erythrocyte [10]. The accumulation of TPx-B
protein is maximal in the early stages of erythrocyte devel-
opment, prior to the appearance of haemoglobin [16].
TPx-B prevents monocyte attachment to endothelial cells
in response to treatment with oxidised low-density
lipoproteins and lipopolysaccharides, with possible impli-
cations in atherosclerosis [17]. In common with other Prx
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enzymes, TPx-B can exist as a mixture of dimers and
oligomers within the cytosol [1,4,12,18]. Oligomers of
TPx-B associated with the plasma membrane have also
been reported [10,13,14,19]. 
The Prx family were predicted to contain a thioredoxin fold,
despite the poor overall sequence identity (<20%) between
Prx proteins and known members of the thioredoxin fold
superfamily [20]. Crystal structures for the 1-Cys Prx
hORF6 [21] and 2-Cys Prx HBP23 [22] were recently
reported, with which TPx-B shares ~30% and ~77% protein
sequence identity, respectively. Both of the previously
reported structures are tightly associated globular homo-
dimers. The subunit has an extended structure divided into
two domains: a thioredoxin-like domain I and a less struc-
tured dimerisation domain II (not defined for HBP23). Dif-
fraction quality crystals of Prx have been reported for
TPx-B purified from human erythrocytes [23] and for AhpC
(alkyl hydroperoxidase reductase subunit C) from
Amphibacillus xylanus [18]. This paper presents the first
crystal structure for an oligomeric Prx, which has been
determined by molecular replacement using the coordinates
for the dimeric hORF06 [21] 1-Cys Prx as a search model. 
Results and discussion
Quality of the model
The structure of the non-recombinant TPx-B enzyme
has been refined to an R factor of 0.192 for all data in the
resolution range 20–1.7 Å without σ cut-off (Table 1).
The refinement excluded 1.0% of the randomly distrib-
uted reflections assigned to calculate the Rfree of 0.256.
The asymmetric unit contains the intact TPx-B decamer.
The quality of the electron density allowed the position-
ing of all the amino acid residues within each subunit.
The root mean square deviation (rmsd) between the Cα
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Table 1
Summary of data collection and model refinement statistics.
Resolution range (Å) 20.0–1.7 (1.73–1.7)§
Completeness (%) 99.6 (93.6)§
Rsym* 0.057 (0.481)§
I/σ<I> 18.8 (2.07)§
Redundancy 4.24 (2.3)§
Unique reflections 228,010
B factor of data from Wilson plot (Å2) 24.4
Final Rcryst† (%) 19.2
Rfree (1.0% total data) (%) 25.6
No. of protein residues 1970
Average B factor protein (Å2) 30.7
No. of water molecules 2194
Average B factor water molecules (Å2) 46.3
Rms deviations from ideality‡
Bond lengths (Å) 0.011 (0.020)
Bond angles (Å) 0.027 (0.040)
1–4 neighbours (Å) 0.031 (0.050)
Planar groups (Å) 0.022 (0.025)
Torsion angles (°)
planar 4.2 (7.0)
staggered 14.3 (15.0)
orthonormal 26.3 (20.0)
B factors correlation (Å2)
mainchain bond 2.5 (4.0)
mainchain angle 3.1 (6.0)
sidechain bond 4.7 (8.0)
sidechain angle 5.9 (10.0)
*Rsym = ΣhΣJ|<Ih> – IJ(h)|/ΣhΣJI(h), where I(h) is the intensity of
reflection h, Σh is the sum over all reflections and ΣJ is the sum over J
measurements of the reflection. †Rcryst = Σ||Fo|–|Fc||/Σ|Fo|. ‡Target
values are given in parentheses. §Values in parentheses are given for
the outer resolution shell.
Figure 1
Stereoview of the 2Fo–Fc electron-density
map at the N terminus of TPx-B contoured at
1σ. The density suggests the absence of the
N-terminal methionine residue and the
carbomylation of Ala2. The figure was
produced using the program BOBSCRIPT
[50]. The carbomylated Ala2 is denoted
as Ncb2.
Ncb2 Ncb2
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positions of the ten subunits is in the range 0.18–0.28 Å.
The electron density suggested that the N terminus is
post-translationally modified, which is consistent with
the resistance of the uncleaved protein to Edman degra-
dation [4,23]. The N-terminal methionine residue was
not observed and the modification of the alanine at posi-
tion 2 was interpreted as carbomylation (Figure 1). The
active-site Cys51 in each subunit is oxidised to cysteine
sulphinic acid (–SO2H). The model also contains 2194
water molecules. The dispersion precision indicator [24]
gives an overall estimate of 0.11 Å for the rms error in the
coordinates for the well-defined part of the structure.
The overall G factor for the stereochemical quality of the
model is 0.0, as calculated using the program
PROCHECK [25], which is within the range of values
expected at 1.7 Å resolution. There are no residues in
the cis conformation. For nonglycine residues, 94% fall
within the most favourable regions of the Ramachandran
plot [26] and there are no residues in unfavourable
regions, as defined by PROCHECK. Approximately 27%
of the amino acids are in α helices, 21% in β sheets and
3% in 310 helices.
Monomer structure
The TPx-B monomer subunit structure is extended and
can be divided into domain I (residues 2–169) and a
C-terminal arm (residues 170–198; Figure 2). Domain I
consists of an extended seven-stranded β sheet, five α
helices and two 310 helices and is related to the domain I
structures of HBP23 and hORF06. A thioredoxin fold is
defined by four of the seven β strands (β3, β4, β6 and β7)
and by four flanking α helices (α1, α2, α4 and α5), where
α1 and α2 in effect constitute a single kinked helix,
equivalent to α2 in hORF06 and HBP23. The seven
β strands are mixed, with topology –1,4x,–1x,–1x,3,1 and
direction –,+,–,–,–,+,– [27]. The C-terminal arm is trun-
cated in comparison to the hORF06 domain II structure,
and consists of a series of loops that culminate with a
C-terminal helix α6. This helix is 30% longer than the
equivalent helix in hORF6 and has a perpendicular orien-
tation (Figure 3). The interaction between domain I and
the C-terminal arm within each subunit is restricted to
hydrophobic interactions involving residues Ala161,
Thr165, Val171 and Trp176, and a single hydrogen bond.
No comparison can be made with the C-terminal arm of
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Figure 2
Structure
(a) (b)
The fold of the TPx-B monomer. (a) Stereoview Cα trace. Each tenth
residue is numbered; the N and C termini are labelled. (b) Ribbon
diagram in the same orientation as (a); α helices are shown in green,
β strands in red and all secondary structure elements are labelled. The
active-site cysteine residues are shown as CPK space-filling models
with the Sγ atoms in yellow and the Cα and Cβ atoms in black. The
figure was produced using the program BOBSCRIPT [50].
st8603.qxd  06/09/2000  11:14  Page 607
608 Structure 2000, Vol 8 No 6
Figure 3
The TPx-B dimer. (a) Stereoview Cα trace. The
twofold axis is normal to the plane of the figure.
The subunits are shown in different colours.
The active-site cysteine residues are shown as
CPK space-filling models; the Sγ atoms are in
yellow and show that the cysteine sidechains
point away from each other. The Cα and Cβ
atoms of the two active-site cysteines are in
black. The sulphinic acid oxygen atoms of
Csd51 are not shown. Secondary structure
elements of the two subunits are labelled.
(b) Stereoview superposition of the Cα traces
of the hORF06 dimer (black/green) and TPx-B
dimer (red/blue) in the same orientation as (a).
The hORF06 active-site cysteine is shown in
pink and the two catalytic cysteines of TPx-B
are shown in blue. Superposition was
performed and refined using the program O
[41]. (c) Stereoview superposition of the Cα
traces of the HBP23 dimer (black/green) and
TPx-B dimer (red/blue) in the same orientation
as (a). The HBP23 disulphide is shown in pink
and the two catalytic cysteines of TPx-B are
shown in blue. For HBP23, only the first six
residues of the C-terminal arm are observed.
Superposition was performed and refined using
the program O [41]. The figure was produced
using the program BOBSCRIPT [50].
(a)
(b)
(c)
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HBP23 because only the first six arm residues are
observed in the structure of HBP23 [22].
Dimer structure
The dimer is compact in comparison to the monomer. The
dimer is ellipsoidal with dimensions 52 Å × 53 Å × 60 Å.
The two monomers are related by a molecular dyad and
the C-terminal arm of one subunit folds over domain I of
the other monomer (Figure 3a). The dimer interface buries
2109 Å2 of solvent-accessible surface area per monomer,
which amounts to 21% of the total subunit surface, in com-
parison to 1700 Å2 and 17.4% for hORF6, respectively.
The β sheets of each subunit combine to form a
14-stranded β sheet, fused between the respective seventh
strands by five mainchain and sidechain hydrogen bonds
involving Arg139, Gln140, Ile141, Val143, Asn144 and
Asp145, and a hydrophobic interaction between Ile141 and
Val143. The monomer–monomer interface is stabilised by
a further 15 hydrogen bonds and 12 hydrophobic interac-
tions between other residues. 
The C-terminal arm makes hydrogen bonds and
hydrophobic interactions with domain I involving
residues 45–54 (loop and helix α1), 90–95 (310 helix) and
145–148 (loop between β7 and α5). These three regions
display different conformations within the HBP23 struc-
ture, which contains a disulphide bond within the active
site (see below). The subunit interactions within the
dimer of all three Prx structures are similar. TPx-B
superimposes against hORF06 with an rmsd of 1.52 Å
between Cα atom positions over 161 of the 220 residues
defined in hORF06 (Figure 3b), and against HBP23 with
an rmsd of 1.08 Å over 161 of 174 residues (Figure 3c).
Each dimer of TPx-B provides a flat rectangular surface
(~40 Å × ~30 Å) at the inner face of the decamer and the
two α4 helices constitute a linear edge with the N termini
loop residues (Figure 4). 
Decamer structure
The TPx-B structure is a toroid-shaped decamer with
point group symmetry 52, constructed from five dimers
(Figure 4). The toroid has a maximal diameter of ~130 Å,
inside diameter of ~60 Å and thickness of ~50 Å. The
interactions at the dimer–dimer interface are mainly
hydrophobic with some water-mediated hydrogen
bonding, burying 630 Å2 of solvent-accessible surface area
per monomer. This gives an overall buried surface area of
2740 Å2 per subunit which amounts to 28% of its surface
area. As shown in Figure 4, subunit A (yellow) makes most
dimer–dimer contacts with subunit D (green) involving
residues Leu45, Phe47, Thr48, Phe81, Ala85, Val107 and
Gly123. Additional ring stability is provided by hydropho-
bic interactions between Phe25 and Leu84 of subunit A
with Val187 of subunit C (red). Although the C-terminal
arm appears disordered within the HBP23 dimer, its struc-
ture is clearly defined and tethered within the TPx-B
decamer, consistent with its crucial role in mediating
dimer–dimer interactions.
The 52 point group symmetry and dimensions of the
decameric TPx-B agree with previous electron microscopy
studies of torin associated with the erythrocyte membrane
[13,14]. There is evidence that decamer formation may be
a general property of Prx enzymes: the self-rotation func-
tion calculated from X-ray diffraction data of bacterial
AhpC Prx also depicts 52 point group symmetry [18], and
a second crystal form of hORF06 [28] was interpreted to
contain 6–12 monomers within the asymmetric unit. Sedi-
mentation studies using the same preparation of protein
that was crystallised confirmed that TPx-B can exist as
decamers at and below its physiological concentration,
which is consistent with TPx-B decamer formation within
the erythrocyte.
In TPx-B, Phe47 within the loop preceding the active-site
helix (α1) is involved in a hydrophobic cluster in which
Phe47, Phe81 and Ala85 from the adjacent dimer also par-
ticipate. In HBP23, however, the partial unwinding of the
active-site helix (see below) forces a change in the rotamer
of Phe47 away from Ala85 towards a potential steric clash
with Phe81 (Figure 5). Movement of residues 89–97 (fol-
lowing helix α3) forces a change in rotamer of Trp86 from
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Figure 4
Ribbon representation of the TPx-B decamer. Monomers are shown in
different colours; the fivefold axis is normal to the plane of the figure.
The active-site cysteine residues are shown as CPK space-filling
models with the Sγ atoms in yellow and the Cα and Cβ atoms in grey.
The figure was produced using the program BOBSCRIPT [50].
Structure
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inside a hydrophobic pocket within domain I onto the
dimer–dimer surface, which would result in a steric clash
with Ala85 from the neighbouring dimer (Figure 5). It is
proposed that such movements would prevent interaction
with another disulphide-bound dimer of TPx-B and hence
decamer formation.
The active site
The active-site Cys51 in TPx-B was interpreted as being
in the oxidised, inactive sulphinic acid form (–SOO–),
denoted as Csd (Figure 6a). Csd51 is positioned at the 
N terminus of helix α1 (Figure 6b), which forms a βαβ
substructure along with the closely associated helix α2 and
the two adjacent parallel strands, β3 and β4. Csd51 is
located within an active-site pocket that opens close to the
dimer–dimer interface. Csd51 is buried, whereas Cys172
is partially exposed.
The active-site pocket around Csd51 is formed by residues
Tyr43*, Pro44**, Thr48**, Val50**, Glu54**, Trp86**,
Arg127** and Arg150** and also by Val171* from the
other subunit (Figure 6b; residues marked * are conserved
only among the 2-Cys mammalian Prx sequences and
residues marked ** are conserved in all mammalian Prx
sequences). Phe81 from the adjacent dimer restricts access
to the active site of the decameric TPx-B. The environ-
ment of Csd51 is therefore predominantly hydrophobic, in
common with HBP23, in which the N-terminal active-site
cysteine (Cys52) is also buried whilst the C-terminal
active-site cysteine (Cys173) is exposed. In TPx-B,
Cys172 is positioned within a hydrophobic pocket defined
by Ala161, Tyr164 and Trp176 from the same subunit, and
by Val148 from the other subunit of the dimer. This apolar
environment, coupled with the limited solvent access,
appears to preserve the thiol status of Cys172 prior to its
involvement in the catalytic cycle (see below) because
there is no evidence for the oxidation of this residue to
sulphenic (–SOH; denoted as Cye) or sulphinic acid. In
contrast, the hORF06 active-site Cye47 is solvent-exposed
and positioned within a narrow positively charged pocket.
In hORF06 the His39 that replaces Tyr43 in TPx-B is
unique to mammalian 1-Cys Prx, and is well positioned to
stabilise Cys47 in the ionised sulphydryl state [21].
The distance between the Cα atoms of Csd51 and Cys172
of the other subunit is ~10 Å; the distance between their
Sγ atoms is ~13 Å because their sidechains point away from
each other (Figure 6b). These two residues are clearly too
far apart to interact with one another or with thioredoxin,
in which the Cα atoms of the redox-active cysteines
(Cys32 and Cys35) are separated by only ~5.5 Å [29].
The active sites of TPx-B, hORF06 and HBP23 are dis-
tinct in terms of their electrostatic interactions. In TPx-B
the sulphinic acid group of the active-site Csd51 makes a
salt bridge with Arg127, whereas in hORF06 the catalytic
Cye47 makes a single hydrogen-bond with the mainchain
amide of the equivalent arginine (Arg132); in HBP23 the
active-site Cys52 does not interact with the equivalent
arginine (Arg128) at all. In TPx-B and HBP23, Glu54/55
makes salt bridges with Arg150/151; in hORF06 the
charge stabilisation of the conserved glutamate (Glu50) is
instead maintained by a salt bridge with Arg132.
The 2-Cys Prx mechanism
Comparisons of the three Prx structures highlight some
aspects of the 2-Cys Prx mechanism. In contrast to the sul-
phinic acid status of Cys51 in TPx-B, the catalytic cys-
teine in hORF06 is oxidised to the reactive sulphenic acid
form Cye47 [30], whereas in HBP23 the corresponding
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Figure 5
Stereoview of the dimer–dimer interface in the
TPx-B decamer (red/blue). Two dimers of
HBP23 (black/green) are superimposed with
the two TPx-B dimers. Dimer–dimer
interaction is hypothetical for HBP23. Protein
backbones are shown as Cα traces; selected
sidechains are depicted as bonds. The
HBP23 sidechains are labelled with an
asterisk. This figure illustrates the role of
residues Phe47, Phe81, Ala85 and Trp86 in
mediating the formation of decamers in TPx-B,
but not in HBP23. Superposition was
performed and refined using the program O
[41]. The figure was produced using the
program BOBSCRIPT [50].
Structure
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Cys52 is oxidised to a disulphide bond with Cys173 of 
the other subunit. Considerable motions are apparent
between TPx-B and HBP23, although only a few of these
can be attributed to differences in sequence. In TPx-B
the α1 helix is five residues longer than the corresponding
helix in HBP23 (Figure 7). In going from the TPx-B to the
HBP23 structure, the loop residues 45–50 preceding helix
α1 have undergone significant conformational changes
and helix α1 has unwound at the N terminus between
residues 51 and 56. Coincident with the helix unwinding
are movements in the positions of three loops in TPx-B:
residues 89–97 that contain the second 310 helix; residues
146–151 (following β7); and residues 169–174 from the
adjacent subunit (within the C-terminal arm following
helix α5; Figure 7). These displacements permit the
approach of the N- and C-terminal catalytic cysteine
residues by 6.6 Å and 4.4 Å from their positions in TPx-B,
culminating in the disulphide-bond formation observed in
the HBP23 structure. The overall effect is to displace and
loosen the C-terminal arm in HBP23, which is disordered
in the crystal structure [22] (Figure 3c).
The TPx-B active site described here is inaccessible to
substrate and has been inactivated by the oxidation of
Cys51 to sulphinic acid (Figure 6a) possibly by hydrogen
peroxide [5]. The formation of the salt bridge between
Csd51 and Arg127 stabilises the decamer observed in this
structure. The oxidation is thought to have occurred
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Figure 6
The TPx-B active site. (a) Stereoview of the
2Fo–Fc electron-density map within the active
site, contoured at 1σ. The electron density
suggests the oxidation of Cys51 to sulphinic
acid (Csd51). (b) Stereoview of the TPx-B
active site looking from the outside towards
helix α1. Protein backbones are shown as
ribbons. The catalytic residues Csd51 and
Cys172 are shown as ball-and-stick models.
Other selected sidechains are shown as
bonds: hydrophobic sidechains are in red,
acidic residues in blue, and basic residues in
green. Hydrogen bonds are depicted as
dashed lines. The figure was produced using
the program BOBSCRIPT [50].
(b)
(a)
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during storage of the erythrocytes prior to enzyme extrac-
tion. TPx-B purified from fresh porcine blood was found
to be a mixture of monomers, dimers and oligomers [4,31]
unlike human TPx-B extracted from one month old blood
packs, which is only decameric.
The structure of the active, reduced 2-Cys Prx is thought
to most closely resemble the presented structure because
within TPx-B the modified Csd51 occupies a similar
conformation to the active Cye47 in the hORF06 struc-
ture, whereas in 2-Cys HBP23 the equivalent residue is
significantly displaced owing to the conformational
changes described above. Within TPx-B, formation of
the sulphinic acid at Cys51 is suggested to disrupt the
electrostatic interactions that exist within the active site
of the reduced, active enzyme, triggered in the first
instance by disruption of a salt bridge between Arg127
and Glu54 (Figure 6b), in analogy with the hORF06
active site [21]. In the reduced, active 2-Cys Prx, the sul-
phydryl sidechain of the N-terminal catalytic cysteine
residue might be stabilised by a hydrogen bond with
Arg127, in analogy with the stabilisation observed
between the equivalent residues within the hORF06
active site [21].
The role of TPx-B decamers in healthy red cells and 
sickle cells
The sedimentation analysis confirms that under physio-
logical protein concentrations (milligrams per millilitre),
the TPx-B decamers show no measurable dissociation into
dimers. TPx-B is therefore suggested to form decamers
within the erythrocyte under conditions of oxidative
stress. ROS damage within erythrocytes is aggravated by
the oxygen-carrying role of haemoglobin and by the per-
oxide-stimulated release of haem iron [3].
In the presence of micromolar calcium concentrations,
cytosolic TPx-B becomes associated as oligomers with the
inner surface of the erythrocyte membrane, which pro-
motes the efflux of potassium ions via the clotrimazole-
sensitive Gardos channels [10,19]. Individuals with sickle
cell disease frequently carry dense sickle cells that
contain elevated levels of calcium and sodium, have
decreased levels of potassium and chloride ions, have a
lowered cytosolic pH (pH 7.14 instead of pH 7.29 in
healthy erythrocytes) and suffer from oxidative stress
[32,33]. These changes result in part from increased
Gardos channel activity [34]. 
Membrane-bound oligomers of TPx-B have been
extracted from erythrocyte ghosts [13–15,19,34]. Calcium
is required for binding [10,15,19] although the mode of
membrane association is unclear. The decameric TPx-B
structure described has no positively charged surface areas
and is, therefore, unlikely to interact directly with phos-
pholipid head groups in the membrane. There are
hydrophobic patches on the outer rim of the torus and
acidic and hydrophobic patches on the torus face that
could enable interaction with membrane-bound proteins
such as stomatin (band 7.2b) [35].
The factors that regulate the interconversion within the
erythrocyte between the two forms of TPx-B, dimers and
decamers, are at present unclear. It is likely that, in vivo,
the formation of cytosolic TPx-B decamers is promoted by
a small decrease in pH [12] and by increases or changes in
the salt concentration, which may coincide with a raised
peroxidase activity [18]. In vivo, the reversible intercon-
version between the two forms of TPx-B is likely to
require Cys51 to be in the reactive sulphenic, thiol or sul-
phydryl state, rather than in the non-reversible, inactive
sulphinic oxidation state observed. The increased associa-
tion of decameric TPx-B with the membrane of sickle
dense cells [34] might result from the changes in pH [32],
and changes in calcium [15] and other cytosolic salt con-
centrations [12], as described above.
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Figure 7
Stereoview superposition of the active sites of
HBP23 and TPx-B. Protein backbones are
shown as ribbons and sidechains as bonds.
The HBP23 backbone is in yellow. Selected
HBP23 sidechains are shown in red and are
labelled with an asterisk. The TPx-B backbone
is in blue with selected sidechains in green.
Superposition was performed and refined
using the program O [41]. An unwinding of
the active-site helix accompanied by changes
in loop conformations and formation of the
active-site disulphide are observed for 2-Cys
Prx. The figure was produced using the
program BOBSCRIPT [50].
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Biological implications
The peroxiredoxin (Prx) family of peroxidases cooperate
with other antioxidant enzymes to regulate the levels of
peroxide and other reactive oxygen species within
tissues. Thioredoxin peroxidase B (TPx-B) is a 2-Cys
mammalian Prx that is the third most predominant
protein within erythrocytes. TPx-B activity is centred
upon the interaction of two conserved cysteine residues,
Cys51 and Cys172, from the two subunits of each
dimer.
The catalytic cycle of 2-Cys Prx requires conforma-
tional changes that include the partial unwinding of the
helix containing Cys51. Formation of the decameric
toroid that is observed in the crystal structure and by
electron microscopy can be induced by oxidation of
Cys51 to cysteine sulphinic acid, whereas disulphide for-
mation favours the dimeric form of TPx-B. 
In vivo, a feature of sickle dense cells is the formation of
TPx-B oligomers, which are associated with the plasma
membrane in a calcium-dependent manner. The
decameric structure of TPx-B will further the under-
standing of the role of Prx enzymes in human disease
related to oxidative stress.
Materials and methods
Crystallisation, data collection and data processing
The TPx-B enzyme was purified and crystallised as previously described
[4,23]. The crystals were obtained by the hanging-drop technique from
16% (v/v) PEG 400 at a protein concentration of 15 mg ml–1. The space
group was determined as monoclinic P21 with cell dimensions a = 88.9 Å,
b = 107.0 Å, c = 119.5 Å, β = 110.9°. For flash-cooling the crystals were
harvested into a mother liquor containing 30% (v/v) PEG 400, 100 mM
Tris-HCl pH 7.5, 10% (v/v) propanol and 10 mM dithioerythreitol. Native
data were collected to 1.7 Å from a single crystal at 100K on the EMBL
X11 beamline at DESY, Hamburg, using a wavelength of 0.9076 Å.
Crystal annealing of the frozen crystal improved its diffraction limit from
2.7 Å to 1.7 Å. The data were processed using DENZO [36] and
SCALEPACK [36] (Table 1). The self-rotation function was calculated by
MOLREP [37] at 10–3 Å resolution with an integration radius of 20 Å
(Figure 8). It clearly indicated that the Prx molecule is a decamer with 52
point group symmetry. The asymmetric unit contains a whole decamer
with molecular mass 218 kDa, giving a solvent content of 48.9%.
Molecular replacement
The structure was solved by molecular replacement using the hORF06
structure (Protein Data Bank [PDB] accession code 1PRX; [21]) as a
search model, rather than the HBP23 structure, as the latter was not
available at the time. The sequence identity between TPx-B and
hORF06 is less than 30%. No molecular replacement solution could
be found with the program AMoRe [38] using either a dimer or a single
subunit of hORF6 as a search model, presumably due to the small per-
centage of the asymmetric unit content that these models represent.
Molecular replacement was attempted with all the possible decamers
with point symmetry 52 which can be created from the known hORF6
dimer by the procedure outlined below. 
Generation of all possible decamers
The polyalanine model of the hORF6 dimer was positioned with its centre
of mass at (X = 0, Y = 0, Z = 0) of the orthogonal coordinate system and
its molecular dyad coincident with the coordinate axis X. Then the dimer
was translated a distance R along the X axis and rotated by φ about its
molecular dyad. The point group symmetry 5 rotations 72°, 144°, –72°
and –144° around the coordinate axis Z were applied to each resulting
dimer at (R, φ) to create the other four dimers of the search decamer (R, φ)
(Figure 9). Inspection of possible packing of the dimers in the decamer
suggested R to be within the range 32–51 Å. Owing to the presence of a
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Figure 8
Self-rotation functions of the TPx-B data calculated using the program
MOLREP [37]. (a) K = 72°. The position of the fivefold axis is shown.
(b) K = 180°. Planes AB and CD each contain five twofold axes
separated by 36°, which are normal to the fivefold axes shown in (a).
These self-rotation functions show that the TPx-B oligomer is a
decamer with 52 point group symmetry.
CA
BD
(a)
(b)
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twofold rotation axis within the dimer, the φ search range was restricted to
0–180°. Two possible types of decamer were generated, one with the
N-terminal face of the dimer pointing towards the centre of the decamer,
and the second with the N-terminal face of the dimer pointing outwards.
1800 possible decamers were generated with 1 Å steps in R and 2°
steps in φ for each type of decamer, which gave 3600 possible decamers.
Translation function with all possible decamers
Molecular replacement studies were carried out using AMoRe [38]. As
the positions of the molecular fivefold axis and the five molecular dyads
were known from the self-rotation function (Figure 8), the cross-rotation
function step of the molecular replacement was omitted. The transla-
tion function search was carried out over a 10–4 Å resolution range
with the 3600 search model decamers rotated according to the self-
rotation function of the TPx-B data. The calculations took less than a
week on a four-processor Silicon Graphics Origin computer. The solu-
tion was found for the decamer at R = 42 Å, φ = 70°, positioned with
the N-terminal side of the dimer facing inwards. It had a correlation
(C = Σ(|Fo| – <|Fo|>)(|Fc| – <|Fc|>)/[Σ(|Fo| – <|Fo|>)2Σ(|Fc| – <|Fc|>)2]1/2)
of 17.4% and an R factor (R = Σ||Fo| – |Fc||/Σ|Fo|) of 55.5%. The best
correlations for the other (wrong) solutions for model decamers never
exceeded 9.7%. 
Model refinement
The model was subjected to rigid-body refinement as implemented in
REFMAC [39] at 10–4 Å. The phases were improved by tenfold noncrys-
tallographic symmetry (NCS) averaging using DM [40]. The model was
then refined with REFMAC using external DM phases. The model was
rebuilt using the program O [41]. Mainchain atoms of all 197 residues
were clearly defined in the electron density. The model was refined
without NCS restraints. Because the data were strongly anisotropic (the
ratio of eigen values of the anisotropic distribution of the structure factors
was 0.51:1.0:0.38 as estimated by SFCHECK [42]), the REFMAC
anisotropic scaling of Fcalc to Fobs was essential for refinement. Water
molecules were added using ARP [43]. The modified Cys51 was
described as a cysteine sulphinic acid (Csd51). The refinement dictionary
entry for the cysteine sulphinic acid was derived from the coordinates for
glutathione synthase (PDB code 1DNC) [44]. The N-terminal residue
Ala2 was originally thought to be modified by acetylation. However, an
attempt to refine this structure using the CCP4 PROTIN [45] dictionary
led to a distortion of the bond lengths and angles. A carbomoylated
alanine as the N-terminal residue was consistent with the electron density,
hydrogen bonding and with the refinement dictionary entry derived from
the coordinates for carbomoylated aspartic acid [46].
Sedimentation equilibrium analysis of TPx-B in solution
The partial specific volume of TPx-B and buffer densities and viscosi-
ties were calculated using SEDNTERP [47]. Purified TPx-B was exten-
sively dialysed against 25 mM Tris-HCl pH 7.0, 1 mM EDTA and
0.1 mM dithioerythrothreitol and its concentration measured as
1.2 mg ml–1, using the experimental extinction coefficient derived for
pig TPx-B, E1%280 = 10 [4]. The protein was diluted with the dialysate to
give a range of protein concentrations from 0.1 to 1.2 mg ml–1. Protein
samples (60 µl) and dialysate (65 µl) were loaded into analytical ultra-
centrifuge cells with six-channel carbon-filled epon centrepieces, to
give a column height of 1.83 mm during centrifugation. The cells were
spun in a Beckman Optima XL-A analytical ultracentrifuge at 6000 rpm
using a Beckman An60-Ti analytical rotor. Solute distributions were
recorded using scanning absorption optics at a wavelength of 280 nm.
When sedimentation equilibrium was attained, the rotor speed was
increased to 9000 rpm until equilibrium was attained once more. After
the final equilibrium was attained, the rotor was accelerated to 45,000
rpm and a baseline absorbance level recorded after 2 h. The equilib-
rium concentration distributions at both rotor speeds and all concentra-
tions were analysed globally using the non-linear least-squares fitting
routine MACNONLIN [48]. 
The equilibrium concentration distributions fit well to a single ideal
species with no indications of self-association or non-ideality from
residuals to the fit. The individual solute distributions for molecular
weight were extrapolated to infinite dilution, which enabled the calcula-
tion of the thermodynamic second virial coefficient, a measure of non-
ideality, alongside the ideal molecular weight. From this extrapolation,
the ideal molecular weight was found to be 224 kDa (±7 kDa), with the
second virial coefficient calculated as 9.2 × 10–5 mol ml g–2. Given that
there may well be errors in the calculated values of partial specific
volume and solvent density, this value of molecular weight indicates
that the protein exists as discrete decamers in solution, over the con-
centration range of 0.1–1.2 mg ml–1 and at pH 7.0, close to the physio-
logical pH of the erythrocyte (pH 7.3). A dissociation constant
describing the interconversion between the decamer and dimer forms
of TPx-B could not be determined because the free dimer concentra-
tion was too low to measure by UV absorbance.
Accession numbers
The structure factors and refined coordinates of human erythrocyte
TPx-B have been deposited with the Brookhaven PDB [49], accession
code 1QMV.
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